相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical efficacy of fosfomycin combinations against a variety of gram-positive cocci
Nieves M. Coronado-Alvarez et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2019)
Genomic characterization of inpatient evolution of MRSA resistant to daptomycin, vancomycin and ceftaroline
Daniel Wuthrich et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Occurrence and Characterization of Methicillin Resistant Staphylococcus aureus in Processed Raw Foods and Ready-to-Eat Foods in an Urban Setting of a Developing Country
Mohammad Aminul Islam et al.
FRONTIERS IN MICROBIOLOGY (2019)
Detection and Molecular Characterization of Staphylococci from Eggs of Household Chickens
Muhammad Ali Syed et al.
FOODBORNE PATHOGENS AND DISEASE (2019)
Antimicrobial consumption and bacterial resistance pattern in patients admitted in ICU at a tertiary care center
Sonal Saxena et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2019)
Novel partners with colistin to increase its in vivo therapeutic effectiveness and prevent the occurrence of colistin resistance in NDM- and MCR-co-producing Escherichia coli in a murine infection model
Yang Yu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Staphylococcus aureus Infections in Malaysia: A Review of Antimicrobial Resistance and Characteristics of the Clinical Isolates, 1990-2017
Ainal Mardziah Che Hamzah et al.
ANTIBIOTICS-BASEL (2019)
The Combination of Daptomycin and Fosfomycin Has Synergistic, Potent, and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus in a Rabbit Model of Experimental Endocarditis
Cristina Garcia-de-la-Maria et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Treatment strategies for persistent methicillin-resistant Staphylococcus aureus bacteraemia
Paul O. Lewis et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2018)
In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Gram-positive cocci isolated from surgical wound infections
Oriana Simonetti et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2018)
Linezolid: a review of its properties, function, and use in critical care
Seyed MohammadReza Hashemian et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Prevalence and molecular characterization of Staphylococcus aureus from human stool samples
A. E. Kates et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2018)
Molecular analysis, biofilm formation, and susceptibility of methicillin-resistant Staphylococcus aureus strains causing community- and health care-associated infections in central venous catheters
Muhammad Sohail et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2018)
Outcomes of Vancomycin plus a β-Lactam versus Vancomycin Only for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
James Truong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
How do fluorescence spectroscopy and multimodal fluorescence imaging help to dissect the enhanced efficiency of the vancomycin-rifampin combination against Staphylococcus aureus infections?
Rym Boudjemaa et al.
PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES (2017)
Detection and Characterization of Staphylococcus aureus and Methicillin-Resistant S-aureus in Foods Confiscated in EU Borders
David Rodriguez-Lazaro et al.
FRONTIERS IN MICROBIOLOGY (2017)
Novel Mutation Sites in the Development of Vancomycin-Intermediate Resistance in Staphylococcus aureus
Yubing Wang et al.
FRONTIERS IN MICROBIOLOGY (2017)
Comparative activities of vancomycin, tigecycline and rifampin in a rat model of methicillin-resistant Staphylococcus aureus osteomyelitis
Paschalis Vergidis et al.
JOURNAL OF INFECTION (2015)
Daptomycin activity tested against 164 457 bacterial isolates from hospitalised patients: Summary of 8 years of a Worldwide Surveillance Programme (2005-2012)
Hello S. Sader et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Novel Combinations of Vancomycin plus Ceftaroline or Oxacillin against Methicillin-Resistant Vancomycin-Intermediate Staphylococcus aureus (VISA) and Heterogeneous VISA
B. J. Werth et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
The first case report of non-nosocomial healthcare-associated infective endocarditis due to methicillin-resistant Staphylococcus aureus USA400 in Rio de Janeiro, Brazil
P. V. Damasco et al.
INFECTION (2013)
Activity of Ceftaroline and Epidemiologic Trends in Staphylococcus aureus Isolates Collected from 43 Medical Centers in the United States in 2009
Sandra S. Richter et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
Benjamin P. Howden et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
Mutated response regulator graR is responsible for phenotypic conversion of Staphylococcus aureus from heterogeneous vancomycin-intermediate resistance to vancomycin-intermediate resistance
Hui-Min Neoh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Functional classification of drugs by properties of their pairwise interactions
P Yeh et al.
NATURE GENETICS (2006)
Characterisation of laboratory-generated vancomycin intermediate resistant Staphylococcus aureus strains
P Bhateja et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
分享论文
